| Incidence and severeness of COVID-19 hospitalization in patients with inflammatory rheumatic disease: a nationwide cohort study from Denmark R Cordtz, J Lindhardsen, BG Soussi, J Vela, L Uhrenholt, R Westermann, ... Rheumatology 60 (SI), SI59-SI67, 2021 | 123 | 2021 |
| Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: a nationwide cohort study … RL Cordtz, K Zobbe, P Højgaard, LE Kristensen, S Overgaard, A Odgaard, ... Annals of the rheumatic diseases 77 (2), 281-288, 2018 | 116 | 2018 |
| Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project LK Mercer, AC Regierer, X Mariette, WG Dixon, E Baecklund, K Hellgren, ... Annals of the rheumatic diseases 76 (12), 2025-2030, 2017 | 94 | 2017 |
| Gender differences in biologic treatment outcomes—a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers P Højgaard, C Ballegaard, R Cordtz, K Zobbe, M Clausen, B Glintborg, ... Rheumatology 57 (9), 1651-1660, 2018 | 78 | 2018 |
| Impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: a population‐based cohort study C Ballegaard, P Højgaard, L Dreyer, R Cordtz, TS Jørgensen, ... Arthritis care & research 70 (4), 592-599, 2018 | 70 | 2018 |
| Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using … RL Cordtz, S Hawley, D Prieto-Alhambra, P Højgaard, K Zobbe, ... Annals of the rheumatic diseases 77 (5), 684-689, 2018 | 69 | 2018 |
| Incidence of hip and knee replacement in patients with rheumatoid arthritis following the introduction of biological DMARDs: an interrupted time-series analysis using … RL Cordtz, S Hawley, D Prieto-Alhambra, P Højgaard, K Zobbe, ... Annals of the rheumatic diseases 77 (5), 684-689, 2018 | 69 | 2018 |
| Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study EH Ibfelt, RK Jacobsen, TI Kopp, RL Cordtz, AS Jakobsen, N Seersholm, ... Rheumatology 60 (1), 346-352, 2021 | 61 | 2021 |
| Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’collaboration K Lauper, M Iudici, D Mongin, SA Bergstra, D Choquette, C Codreanu, ... Annals of the rheumatic diseases 81 (10), 1358-1366, 2022 | 55 | 2022 |
| Risk of multiple sclerosis during tumour necrosis factor inhibitor treatment for arthritis: a population-based study from DANBIO and the Danish Multiple Sclerosis Registry L Dreyer, M Magyari, B Laursen, R Cordtz, F Sellebjerg, H Locht Annals of the Rheumatic Diseases 75 (4), 785-786, 2016 | 49 | 2016 |
| Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study L Dreyer, RL Cordtz, IMJ Hansen, LE Kristensen, ML Hetland, ... Annals of the Rheumatic Diseases 77 (4), 510-514, 2018 | 48 | 2018 |
| Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis-A nationwide cohort study from the … A Egeberg, NAL Rosenø, D Thein, EH Lørup, ML Nielsen, L Nymand, ... Seminars in Arthritis and Rheumatism 53, 151979, 2022 | 41 | 2022 |
| Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden TI Kopp, B Delcoigne, EV Arkema, RK Jacobsen, M Magyari, EH Ibfelt, ... Annals of the Rheumatic Diseases 79 (5), 566-572, 2020 | 41 | 2020 |
| Secular trends in the incidence and prevalence of gout in Denmark from 1995 to 2015: a nationwide register-based study K Zobbe, D Prieto-Alhambra, R Cordtz, P Højgaard, JS Hindrup, ... Rheumatology 58 (5), 836-839, 2019 | 41 | 2019 |
| Incidence of COVID-19 hospitalisation in patients with systemic lupus erythematosus: a nationwide cohort study from Denmark R Cordtz, S Kristensen, LPH Dalgaard, R Westermann, K Duch, ... Journal of clinical medicine 10 (17), 3842, 2021 | 29 | 2021 |
| Association between NICE guidance on biologic therapies with rates of hip and knee replacement among rheumatoid arthritis patients in England and Wales: an interrupted time … S Hawley, R Cordtz, L Dreyer, CJ Edwards, NK Arden, A Delmestri, ... Seminars in arthritis and rheumatism 47 (5), 605-610, 2018 | 28 | 2018 |
| COVID-19 infection and hospitalization risk according to vaccination status and DMARD treatment in patients with rheumatoid arthritis R Cordtz, S Kristensen, R Westermann, K Duch, F Pearce, J Lindhardsen, ... Rheumatology 62 (1), 77-88, 2023 | 23 | 2023 |
| Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis R Cordtz, L Mellemkjær, B Glintborg, ML Hetland, L Dreyer Annals of the Rheumatic Diseases 74 (7), 1479-1480, 2015 | 22 | 2015 |
| Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: a register-based cohort study from Denmark R Cordtz, A Odgaard, LE Kristensen, S Overgaard, L Dreyer Seminars in Arthritis and Rheumatism 50 (1), 30-35, 2020 | 20 | 2020 |
| Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: a Danish nationwide cohort study R Westermann, K Zobbe, R Cordtz, JH Haugaard, L Dreyer Lupus 30 (5), 752-761, 2021 | 16 | 2021 |
Daniel Prieto-alhambraProfessor, university of oxford and Erasmus MCVerified email at idiapjgol.info
